[Confectionary News] Are functional jellies and candy a good fit for the confectionery sector?
ConfectioneryNews looks at some of the benefits, and also the issues, of using dietary and medicinal ingredients in sweets. The use of confectionery products to carry over-the-counter (OTC) medications or dietary supplements is increasing as consumers realise that hard candy, jellies or fruit products are one of the quickest ways of getting nutrients into the body. The demand for functional jellies continues to grow with herbal extracts, cannabinoids and vitamins proving a good fit with the mainstream candy sector.
Briefing on UN CND vote and EC CBD Ruling
Following another pivotal day for the industry, the ACI held a briefing webinar for our members on Friday 4 Dec 2020. News had just broken that the European Commission has reversed its stance that CBD be regulated as a narcotic. The ramifications for members are clear, and we updated them on our position during this briefing. The following […]
[Health Europa] EU court rules CBD is ‘not a narcotic’
The ruling is a boost to the CBD sector in Europe after the EU decision to potentially classify CBD as a narcotic. The court stated that: ‘A Member State may not prohibit the marketing of cannabidiol (CBD) lawfully produced in another Member State when it is extracted from the Cannabis sativa plant in its entirety and not solely from its fibre and seeds.’ And that: ‘the provisions on the free movement of goods within the European Union (Articles 34 and 36 TFEU) are applicable, since the CBD at issue in the main proceedings cannot be regarded as a ‘narcotic drug’.’
[New Food Magazine] CBD: What companies and retailers need to know
The CBD sector is notoriously confusing. Here, the Association for the Cannabinoid Industry offers sound advice for staying ahead and remaining compliant.
[Food Navigator] ‘A breakthrough for the market’: Europe’s highest court rules CBD is not a narcotic
Europe’s CBD market is optimistic a ruling from the EU’s highest court not to classify the ingredient a narcotic – going against the European Commission’s shock preliminary view in July – will pave the way for Novel Food applications for CBD products to re-start.
The Court of Justice of the European Union ruled CBD is not a narcotic drug as it “does not appear to have any psychotropic effect or any harmful effect on human health”.
Event report: CBD Live USA
The ACI and our sister organisation the CMC are educational partners for the upcoming CBD Live USA. Registration is free and will grant you access to the virtual exhibition hall and live events that will be running throughout the three day event. Where: onlineWhen: November 18-20, 2020Time: 10:00 – 18:00, Central Time, US Register now
ACI Welcomes CJEU CBD Ruling
The ACI welcomes today’s ruling from the Court of Justice of the European Union (CJEU) which marks a landmark day for the CBD industry.
ACI Meets Demand For Novel Foods Advice By Strengthening Regulatory Consultancy Team
The ACI is pleased to announce an additional new hire to enable us to meet the demand from CBD companies seeking guidance from our Regulatory Consultancy Team to finalise their novel foods applications.
[Analytical Cannabis] Inside the ACI’s CBD Safety Trial
The UK’s CBD industry is about to hit a crossroads. In just under five months’ time, every CBD company in the country will fall on one side of a new divide: those that have submitted a novel foods application with the country’s Food Standards Agency (FSA), and those that have not. To learn more about these time constraints and just what a CBD toxicology is, Analytical Cannabis spoke with Dr Paul Duffy, the ACI’s lead toxicologist.
[Analytical Cannabis] Proving CBD’s Safety in the UK
To find out more about ACI’s safety studies, the future of CBD in the UK, and what it takes to pass a novel foods assessment, Analytical Cannabis caught up with the ACI’s regulatory lead, Dr Parveen Bhatarah.
